Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
67
TWST Quote, Financials, Valuation and Earnings
Last price:
$32.82
Seasonality move
:
6.31%
Day range:
$30.42 - $33.21
52-week range:
$23.30 - $55.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.24x
P/B ratio:
4.24x
Volume:
1.2M
Avg. volume:
1.7M
1-year change:
-37.42%
Market cap:
$2B
Revenue:
$376.6M
EPS (TTM):
-$1.31
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
$97.4M | -$0.50 | 13.1% | -2.62% | $35.63 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
LFWD
Lifeward Ltd.
|
$6.3M | -$0.16 | 6.19% | -94.81% | $5.17 |
|
VNRX
VolitionRX Ltd.
|
$715.6K | -$0.05 | 272.5% | -33.67% | $2.60 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$32.7M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
$32.81 | $35.63 | $2B | -- | $0.00 | 0% | 5.24x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.3900 | $12.3077 | $177.7M | -- | $0.00 | 0% | 162.05x |
|
LFWD
Lifeward Ltd.
|
$0.70 | $5.17 | $12.4M | -- | $0.00 | 0% | 0.33x |
|
VNRX
VolitionRX Ltd.
|
$0.31 | $2.60 | $38.2M | -- | $0.00 | 0% | 21.34x |
|
VTAK
Catheter Precision, Inc.
|
$2.42 | -- | $3M | 0.40x | $0.00 | 0% | 11.38x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.61 | $1.50 | $85.4M | 59.83x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
13.78% | 0.720 | 4.43% | 3.17x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
LFWD
Lifeward Ltd.
|
1.82% | -1.723 | 1.98% | 0.94x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
TWST
Twist Bioscience Corp.
|
$50.8M | -$29.9M | -14.27% | -16.74% | -30.24% | -$24.2M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
LFWD
Lifeward Ltd.
|
$2.7M | -$3.1M | -146.07% | -150.63% | -50.69% | -$3.8M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Twist Bioscience Corp. vs. Competitors
-
Which has Higher Returns TWST or CATX?
Perspective Therapeutics, Inc. has a net margin of -27.41% compared to Twist Bioscience Corp.'s net margin of -12425.36%. Twist Bioscience Corp.'s return on equity of -16.74% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.51.35% -$0.45 $548.5M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About TWST or CATX?
Twist Bioscience Corp. has a consensus price target of $35.63, signalling upside risk potential of 8.58%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 414.97%. Given that Perspective Therapeutics, Inc. has higher upside potential than Twist Bioscience Corp., analysts believe Perspective Therapeutics, Inc. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.6 1 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is TWST or CATX More Risky?
Twist Bioscience Corp. has a beta of 2.242, which suggesting that the stock is 124.157% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock TWST or CATX?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or CATX?
Twist Bioscience Corp. quarterly revenues are $99M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Twist Bioscience Corp.'s net income of -$27.1M is lower than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 5.24x versus 162.05x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.5.24x -- $99M -$27.1M CATXPerspective Therapeutics, Inc.162.05x -- $209K -$26M
-
Which has Higher Returns TWST or LFWD?
Lifeward Ltd. has a net margin of -27.41% compared to Twist Bioscience Corp.'s net margin of -51.17%. Twist Bioscience Corp.'s return on equity of -16.74% beat Lifeward Ltd.'s return on equity of -150.63%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.51.35% -$0.45 $548.5M LFWDLifeward Ltd.43.7% -$0.20 $13M -
What do Analysts Say About TWST or LFWD?
Twist Bioscience Corp. has a consensus price target of $35.63, signalling upside risk potential of 8.58%. On the other hand Lifeward Ltd. has an analysts' consensus of $5.17 which suggests that it could grow by 638.1%. Given that Lifeward Ltd. has higher upside potential than Twist Bioscience Corp., analysts believe Lifeward Ltd. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.6 1 0 LFWDLifeward Ltd.2 0 0 -
Is TWST or LFWD More Risky?
Twist Bioscience Corp. has a beta of 2.242, which suggesting that the stock is 124.157% more volatile than S&P 500. In comparison Lifeward Ltd. has a beta of 0.010, suggesting its less volatile than the S&P 500 by 99.011%.
-
Which is a Better Dividend Stock TWST or LFWD?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lifeward Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Lifeward Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or LFWD?
Twist Bioscience Corp. quarterly revenues are $99M, which are larger than Lifeward Ltd. quarterly revenues of $6.2M. Twist Bioscience Corp.'s net income of -$27.1M is lower than Lifeward Ltd.'s net income of -$3.2M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Lifeward Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 5.24x versus 0.33x for Lifeward Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.5.24x -- $99M -$27.1M LFWDLifeward Ltd.0.33x -- $6.2M -$3.2M
-
Which has Higher Returns TWST or VNRX?
VolitionRX Ltd. has a net margin of -27.41% compared to Twist Bioscience Corp.'s net margin of -862.39%. Twist Bioscience Corp.'s return on equity of -16.74% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.51.35% -$0.45 $548.5M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About TWST or VNRX?
Twist Bioscience Corp. has a consensus price target of $35.63, signalling upside risk potential of 8.58%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 734.94%. Given that VolitionRX Ltd. has higher upside potential than Twist Bioscience Corp., analysts believe VolitionRX Ltd. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.6 1 0 VNRXVolitionRX Ltd.4 2 0 -
Is TWST or VNRX More Risky?
Twist Bioscience Corp. has a beta of 2.242, which suggesting that the stock is 124.157% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock TWST or VNRX?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or VNRX?
Twist Bioscience Corp. quarterly revenues are $99M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Twist Bioscience Corp.'s net income of -$27.1M is lower than VolitionRX Ltd.'s net income of -$5.4M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 5.24x versus 21.34x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.5.24x -- $99M -$27.1M VNRXVolitionRX Ltd.21.34x -- $627.3K -$5.4M
-
Which has Higher Returns TWST or VTAK?
Catheter Precision, Inc. has a net margin of -27.41% compared to Twist Bioscience Corp.'s net margin of -1037.17%. Twist Bioscience Corp.'s return on equity of -16.74% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.51.35% -$0.45 $548.5M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About TWST or VTAK?
Twist Bioscience Corp. has a consensus price target of $35.63, signalling upside risk potential of 8.58%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1470.3%. Given that Catheter Precision, Inc. has higher upside potential than Twist Bioscience Corp., analysts believe Catheter Precision, Inc. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.6 1 0 VTAKCatheter Precision, Inc.0 0 0 -
Is TWST or VTAK More Risky?
Twist Bioscience Corp. has a beta of 2.242, which suggesting that the stock is 124.157% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock TWST or VTAK?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or VTAK?
Twist Bioscience Corp. quarterly revenues are $99M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Twist Bioscience Corp.'s net income of -$27.1M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 5.24x versus 11.38x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.5.24x -- $99M -$27.1M VTAKCatheter Precision, Inc.11.38x 0.40x $226K -$2.3M
-
Which has Higher Returns TWST or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -27.41% compared to Twist Bioscience Corp.'s net margin of 3.93%. Twist Bioscience Corp.'s return on equity of -16.74% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital TWSTTwist Bioscience Corp.51.35% -$0.45 $548.5M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About TWST or XTNT?
Twist Bioscience Corp. has a consensus price target of $35.63, signalling upside risk potential of 8.58%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 145.78%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Twist Bioscience Corp., analysts believe Xtant Medical Holdings, Inc. is more attractive than Twist Bioscience Corp..
Company Buy Ratings Hold Ratings Sell Ratings TWSTTwist Bioscience Corp.6 1 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is TWST or XTNT More Risky?
Twist Bioscience Corp. has a beta of 2.242, which suggesting that the stock is 124.157% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock TWST or XTNT?
Twist Bioscience Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Twist Bioscience Corp. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios TWST or XTNT?
Twist Bioscience Corp. quarterly revenues are $99M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Twist Bioscience Corp.'s net income of -$27.1M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Twist Bioscience Corp.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 59.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Twist Bioscience Corp. is 5.24x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income TWSTTwist Bioscience Corp.5.24x -- $99M -$27.1M XTNTXtant Medical Holdings, Inc.0.67x 59.83x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 222.7% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is up 1.39% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 2.34% over the past day.
